Jaguar Health, Inc.
(NASDAQ : JAGX)

( )
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards

...

News

...
Health Technology » Pharmaceuticals Generic

Company Profile

Jaguar Health, Inc. engages in the dvelopment of gastrointestinal products for both human prescription use and animals. Its products include Mytesi, Canalevia, Equilevia, and Neonorm. The Mytesi product IS use for relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Canalevia product is intended for treatment of diarrhea in dogs. The Equilevia product is a non-prescription product for gut health in equine athletes. The Neonorm product is a non-prescription animal products. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.